TFGT
TAK icon

TS Financial Group (TSFG)’s Takeda Pharmaceutical TAK Stock Holding History

TS Financial Group (TSFG)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$125K Buy
7,796
+192
+3% +$3.18K 0.02% 248
2026
Q1 		$141K Sell
7,604
-135
-2% -$2.37K 0.02% 216
2025
Q4 		$121K Sell
7,739
-8,373
-52% -$120K 0.02% 227
2025
Q3 		$236K Buy
16,112
+93
+0.6% +$1.38K 0.04% 160
2025
Q2 		$248K Sell
16,019
-6,529
-29% -$96.5K 0.04% 153
2025
Q1 		$335K Sell
22,548
-2,278
-9% -$31.9K 0.07% 123
2024
Q4 		$329K Sell
24,826
-324
-1% -$4.45K 0.07% 122
2024
Q3 		$358K Sell
25,150
-489
-2% -$6.94K 0.08% 114
2024
Q2 		$332K Buy
25,639
+1,965
+8% +$26K 0.08% 113
2024
Q1 		$329K Sell
23,674
-1,072
-4% -$15.6K 0.08% 117
2023
Q4 		$353K Sell
24,746
-3,369
-12% -$47.8K 0.11% 105
2023
Q3 		$435K Sell
28,115
-9,532
-25% -$148K 0.16% 91
2023
Q2 		$591K Sell
37,647
-588
-2% -$9.63K 0.22% 70
2023
Q1 		$630K Buy
38,235
+665
+2% +$10.6K 0.23% 66
2022
Q4 		$586K Sell
37,570
-125
-0.3% -$1.75K 0.23% 67
2022
Q3 		$489K Buy
37,695
+2,458
+7% +$34.2K 0.23% 60
2022
Q2 		$495K Hold
35,237
– – 0.21% 63
2022
Q1 		$505K Sell
35,237
-4,036
-10% -$59.3K 0.18% 65
2021
Q4 		$535K Sell
39,273
-1,371
-3% -$19.2K 0.19% 64
2021
Q3 		$666K Sell
40,644
-2,963
-7% -$49.7K 0.26% 56
2021
Q2 		$734K Sell
43,607
-1,237
-3% -$21.1K 0.3% 52
2021
Q1 		$819K Sell
44,844
-2,212
-5% -$39.8K 0.42% 36
2020
Q4 		$856K Sell
47,056
-1,891
-4% -$33.2K 0.46% 34
2020
Q3 		$873K Sell
48,947
-29
-0.1% -$528 0.52% 27
2020
Q2 		$878K Buy
48,976
+453
+0.9% +$8.13K 0.58% 26
2020
Q1 		$737K Buy
48,523
+155
+0.3% +$2.81K 0.66% 27
2019
Q4 		$954K Buy
48,368
+69
+0.1% +$1.32K 0.71% 28
2019
Q3 		$831K Buy
48,299
+45
+0.1% +$778 0.64% 28
2019
Q2 		$854K Buy
48,254
+459
+1% +$8.35K 0.69% 28
2019
Q1 		$974K Buy
+47,795
New +$962K 0.83% 26

Other funds holding TAK

CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CCA
Catalyst Capital Advisors Huntington, New York $6.03B AUM 24.5% 1-Year Est. Return
LWAM
Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return

TS Financial Group (TSFG)'s TAK Position: Q2 2026 in Review

TS Financial Group (TSFG) increased its Takeda Pharmaceutical (TAK) stake by 2.5% in Q2 2026, buying an estimated $3.18K and bringing the position to 7,796 shares worth $125K. The position accounts for 0.02% of the portfolio, ranked #248.

TS Financial Group (TSFG) first reported a position in TAK in Q1 2019 and has held it in 30 quarters since. The position peaked at $974K in Q1 2019. 104 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • TS Financial Group (TSFG) held 7,796 shares of Takeda Pharmaceutical worth $125K as of Q2 2026.
  • TS Financial Group (TSFG) bought 192 Takeda Pharmaceutical shares in Q2 2026, an estimated $3.18K.
  • Takeda Pharmaceutical made up 0.02% of TS Financial Group (TSFG)'s portfolio in Q2 2026, its #248 holding.
  • TS Financial Group (TSFG) first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 30 quarters since.
  • TS Financial Group (TSFG)'s Takeda Pharmaceutical position peaked at $974K in Q1 2019.
  • 104 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.